Compare FedEx Corporation (FDX) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FedEx Corporation vs GE HealthCare Technologies Inc. Common Stock — how do they compare? FedEx Corporation trades at $290.92 (market cap $68.94B), while GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B). The key difference: FedEx Corporation is far larger — about 2.2× GE HealthCare Technologies Inc. Common Stock's market cap, and FedEx Corporation pays the higher dividend (1.68%). Which is the better fit depends on your goals.
| FDX | GEHC | |
|---|---|---|
Market Cap | $68.94B | $30.93B |
Volume | 1,120,376 | 5,033,451 |
Sector | Industrials | Health |
52-Week High | $339.35 | $88.16 |
52-Week Low | $189.87 | $59.48 |
Typical Hold Time | 87 Days | — |
Enterprise Value | $98.57B | $39.39B |
Dividend Yield | 1.68% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FedEx (FDX) trades at $290.59, down 0.56% on the day, with a bearish technical signal and mixed oscillators. The company shows stable profitability with a net income margin of 4.68% and a P/E of 15.67, while recent earnings beats and a $300 million electric truck order from Harbinger highlight operational momentum. Cash flow trends indicate a projected rebound in 2026 to $7.8 billion net cash flow.
The outlook is cautiously optimistic, supported by analyst consensus favoring Buy ratings (57%) and a $307.55 price target. Key risks include exposure to fuel price volatility and competitive pressures, but strong institutional backing and dividend payments provide stability for long-term investors.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
